淋巴显像与SPECT/CT在血管化淋巴结移植治疗淋巴水肿中的预后价值
本研究纳入55例接受血管化淋巴结移植的淋巴水肿患者(57条肢体),术后12个月行淋巴显像,部分加做SPECT/CT。结果显示移植淋巴结有放射性摄取组的主观症状改善率(77.4% vs 38.5%,P=0.003)和TLS分级改善率(55.6% vs 9.1%,P<0.001)均显著高于无摄取组,且摄取组蜂窝织炎频率显著下降(P=0.010)。淋巴显像联合SPECT/CT可能有助于评估VLNT术后结局。
要点
- 移植淋巴结放射性摄取者主观症状改善率与TLS分级改善率均显著更高。
- 有摄取组蜂窝织炎发生频率显著下降,无摄取组未见显著变化。
- TLS分级改善与SUVmax呈显著正相关(r=0.463,P=0.045)。
核心结论
- 淋巴显像联合SPECT/CT可能作为评估VLNT治疗淋巴水肿术后手术结局的预后工具。
研究设计与样本
- 纳入2019年3月至2023年9月接受VLNT的淋巴水肿患者,共55例患者57条肢体;所有患者术后12个月行淋巴显像,研究后期部分加做SPECT/CT。
主要发现
- 术后淋巴显像显示31条肢体(54.4%)移植淋巴结有阳性放射性摄取。
- 有摄取组主观症状改善率为77.4%,无摄取组为38.5%(P=0.003)。
- 有摄取组TLS分级改善率为55.6%,无摄取组为9.1%(P<0.001)。
- 有摄取组蜂窝织炎频率显著下降(P=0.010),无摄取组无显著变化(P=0.211)。
- 24例加做SPECT/CT的患者中,有摄取者70%达到TLS分级改善(P=0.006);TLS分级改善与SUVmax正相关(r=0.463,P=0.045)。
临床怎么用
- 对VLNT术后淋巴水肿患者,术后12个月可行淋巴显像评估移植淋巴结摄取情况以辅助判断预后。
- 移植淋巴结无放射性摄取者症状与TLS分级改善比例较低,需加强随访与干预。
- SPECT/CT所测SUVmax与TLS分级改善正相关,可作为补充评估指标。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This study aimed to evaluate the prognostic value of postoperative lymphoscintigraphy and SPECT/CT in assessing clinical outcomes in lymphedema patients undergoing vascularized lymph node transfer (VLNT). PATIENTS AND METHODS: Lymphedema patients who underwent VLNT between March 2019 and September 2023 were included in the study. All patients underwent postoperative lymphoscintigraphy 12 months after surgery. In addition to lymphoscintigraphy, SPECT/CT was performed during the later phase of the study period. Patient demographics, clinical stage, recipient site, and lymph node flap type, and lymphoscintigraphic findings were recorded and analyzed in relation to clinical outcomes. RESULTS: Among the 57 extremities of 55 patients, postoperative lymphoscintigraphy showed positive radiotracer uptake in transferred lymph nodes in 31 extremities (54.4%). There were significantly higher rates of both subjective symptom improvement (77.4% vs 38.5%, P = 0.003) and Taiwan lymphoscintigraphy staging (TLS) grade improvement (55.6% vs 9.1%, P < 0.001) among patients with uptake compared with those without uptake. In addition, the frequency of cellulitis was significantly decreased in the uptake group ( P = 0.010) but not in the non-uptake group ( P = 0.211). A subset of 24 patients underwent SPECT/CT in addition to lymphoscintigraphy. Lymphoscintigraphic assessment revealed that 70% of patients with uptake achieved TLS grade improvement ( P = 0.006). Spearman rank correlation analysis demonstrated a significant positive correlation between TLS grade improvement and SUV max (correlation coefficient = 0.463, P = 0.045). CONCLUSIONS: Lymphoscintigraphy with SPECT/CT may serve as a valuable prognostic tool for evaluating surgical outcomes following VLNT in lymphedema treatment.
引用
- Cho J, Kim SM, Lee H, et al. Prognostic Value of Lymphoscintigraphy and SPECT/CT After Vascularized Lymph Node Transfer in Lymphedema Patients. Clin Nucl Med. 2026. PMID: 41543874. doi:10.1097/RLU.0000000000006299
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。